Prediction of potassium extraction rates by continuous haemodiafiltration (CHDF) is useful for safe management of potassium levels in patients with hyperkalaemia. For this purpose, we developed a formula to predict the quantity of potassium extracted by CHDF.
Hyperkalaemia is a frequent and potentially lifethreatening medical problem for critically ill patients. The principal treatment approach to hyperkalaemia is drug therapy 1 . However, in cases of progressive hyperkalaemia or in patients experiencing renal failure, the efficacy of intermittent renal replacement therapy (RRT) is also well established 2, 3 . Recently, the treatment of critically ill patients by RRT has shifted toward continuous haemodiafiltration (CHDF) because of its excellent haemodynamic stability 4 . Potassium removal using CHDF is now a common therapeutic approach to management of hyperkalaemia in critical care settings. However, intermittent RRT has demonstrated more rapid removal of potassium than CHDF because of the small clearance volume of CHDF. It is essential, therefore, to accurately predict the amount of potassium removal by CHDF to enable rapid normalization of potassium concentrations.
The aim of the present study was to establish a formula that can predict the amount of potassium removed by CHDF. For this purpose, we constructed a potassium simulation model for the CHDF column, and examined the validity of this model by comparing calculated and measured values of potassium concentration. We thereby developed a formula for estimating potassium removal from a given set of CHDF parameters.
MATERIALS AND METHODS

Potassium simulation model
If potassium is not absorbed by the CHDF column, the total amount of potassium influx through the blood and dialysate is equal to the efflux: We assumed that potassium concentration in efflux dialysate is equal to the potassium concentration in influx blood because 1) potassium freely diffuses through the column membrane, 2) convection between blood and dialysate creates a potassium concentration gradient along the length of the column, and 3) Qb [0.1-0.2 l/min=6-12 l/h] is usually greater than Qd [1-3 l/h]. Therefore,
From [1] and [2] , the calculated potassium concentration in efflux blood (Cb [out] calc ) was as follows:
Sample collection
The study was approved by the Human Ethics Committee of the Emergency and Intensive Care Center, Otsu Municipal Hospital, and informed consent was obtained from all patients. Thirty-four patients (21 males and 13 females) with a mean age of 66±13 y (range 33-86) participated in the study. The patients were admitted to the Intensive Care Unit of Otsu Municipal Hospital between June 1, 1999 and February 15, 2000. All participants underwent CHDF for acute renal failure. Cases of hypokalaemia (<3 mmol/l) were excluded from the present study. CHDF therapy was applied three times in 25 patients, twice in five patients and once in four patients. Thus, a total of 89 measurements were recorded. CHDF was performed exclusively with the JUN-500 (Ube Co. Ltd., Japan). Vascular access was obtained using a 12 Fr double lumen catheter (Arrow International, PA) inserted into the femoral vein. Fluid with potassium concentration of 2.0 mmol/l was used as the dialysate and as replacement fluid (HF-solita: Shimizu Chemical Co. Ltd., Japan). Fifty minutes after starting CHDF therapy, blood samples were collected through the inlet and outlet sampling ports of the CHDF circuit. Potassium concentration of the blood samples was measured by a blood analyser (Stat Profile-M: Nova Co. Ltd., U.S.A.; mean error <3.0%).
CHDF protocol
The present study consisted of 12 independent experimental groups conducted to explore the effects of Qd, Qb, and Qf on potassium removal (Table 1) . Before starting measurement, the CHDF setting was randomly decided. Randomization was performed according to a protocol blindly chosen from these groups (1-A or 3-B, etc.). During measurement, CHDF was performed according to the parameter settings of the group.
Data comparison
Cb 
RESULTS
The number of measurements and plasma potassium concentration just before CHDF treatment in each experimental group is shown in Table 2 . Mean plasma potassium concentration was 4.38± 0.79 mmol/l (range, 3.1-5.9 mmol/l), and mean potassium concentration of efflux blood was 3.64± 0.64 mmol/l (range, 2.3-5.3 mmol/l). Plasma potassium concentration did not differ significantly between groups. Figure 1 presents a Table 3 . The largest confidence interval ranged from -0.37 to 0.69 mmol/l in group 1-C. However, no obvious differences in the confidence intervals were found between these experimental groups. Overall bias of Cb [out] was 0.13±0.23 mmol/l (95% confidence range, -0.32 to 0.58 mmol/l).
DISCUSSION
Accuracy of the equation
We observed minimal differences between measured and calculated Cb [out] under various CHDF settings. Therefore, our simulation accurately predicted potassium concentrations. Our data indicate that potassium was ideally distributed through the column, and the column did not deteriorate due to increases in Qd or Qf within the ranges of standard clinical use.
Calculation of potassium extraction
Based upon the equation [3] , we developed a formula to predict the amount of potassium extracted by CHDF. This amount was assumed to be equal to the difference in potassium content between the two sides of the column. Thus, the extracted amount of potassium (dK) is calculated by following equation: [4] where Cs is potassium concentration in replacement fluid for ultrafiltration and Qs is infusion rate of replacement fluid. Cb [in] is generally equivalent to plasma potassium levels (Cb). Cd [in] is potassium concentration in dialysate fluid (Cd).
From [3] and [4] :
dK=(Cb-Cd)xQd+CbxQf-CsxQs [5] According to this formula, increases in either Qd or Qf would facilitate potassium extraction. In contrast, Qb was removed from the formula, demonstrating that alteration of this parameter has no effect on potassium extraction. This is consistent with a previous report that CHDF clearance is limited by Qd and Qf 6 . Formula [5] can be further simplified if the potassium concentration in dialysate is equal to that of replacement fluid, and ultrafiltration rate is equal to the infusion rate of replacement fluid.
Therefore, dialysis and ultrafiltration, although they are based on completely different mechanisms, were found to have the same effect on potassium extraction.
Potassium concentrations in dialysate and replacement fluid are also important factors for determining potassium extraction efficacy. For instance, for a patient with a potassium concentration of 6 mmol/l, CHDF with: Qd=2 l/h, Cd=2 mmol/l has the same effect as CHDF with: Qd=1.3 l/h, Cd=0 mmol/l. Therefore, the use of potassium-free dialysate and replacement fluid can be recommended during treatment of hyperkalaemia. Clinical use of the potassium removal formula Formula [5'], above, enables us to estimate potassium extraction from CHDF quite easily. For instance, a theoretical patient whose potassium concentration is 8 mmol/l receives CHDF therapy with: Qd=1 l/h, Qf: 0.1 l/h and Cd=2 mmol/l is calculated to undergo potassium extraction at a rate of 6.6 mmol/h. Maximum potassium extraction for this patient is 24.8 mmol/h under dialysis at a rate of 2000 ml/h, filtration at 450 ml/h, and use of potassium-free fluid.
Assuming that extracted potassium amount [∫(CbxdQ/dt)] can be approximated as Σ(CbxQxt) over small discrete time intervals, the potassium concentration at any time point during CHDF is described as follows:
where Cb(t) is potassium concentration t minutes after starting CHDF, and V indicates extracellular fluid volume. Time intervals for the simulation were calculated every one minute. Table 4 shows simulation results from a patient whose ECF volume was 15 l and initial potassium concentration is 8.0 mmol/l. Prediction of potassium extraction is also important for patients with normal potassium concentrations receiving CHDF therapy. Severe hypokalaemia is sometimes observed during CHDF therapy without sufficient potassium replacement 7 . The efficacy of potassium infusion therapy is already well established in hypokalaemic critically ill patients 8 . Our formula enables simple calculation of appropriate potassium infusion needed during CHDF. A patient whose potassium concentration is 4.5 mmol/l will lose potassium at a rate of 2 mmol/h under CHDF therapy of 700 ml/h Qd, 300 ml/h Qf, and 2 mmol/l potassium replacement fluid. Therefore, a potassium supplement of 48 mmol/day is necessary to maintain initial potassium levels.
Limitations of the study
Some limitations must be emphasised. Plasma potassium level was simulated using a single compartment model, and did not refer to potassium transported across the cellular membrane. Calculations were made every minute in plasma potassium estimation, whereas decreases in potassium occur in a continuum. Credibility of this simulation, therefore, needs to be established with comparisons to the measured data.
CONCLUSION
A simple formula was developed to predict the amount of potassium extracted by CHDF. The validity of the formula was established under clinical application of CHDF. This formula is quite simple, easy to use, and accurately predicts potassium extraction. Our formula can assist in the formulation of clinical strategies for the treatment of hyperkalaemia with CHDF. 
